NM_000834.5:c.3534C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000834.5(GRIN2B):​c.3534C>T​(p.His1178His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.461 in 1,613,184 control chromosomes in the GnomAD database, including 184,050 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 12927 hom., cov: 32)
Exomes 𝑓: 0.47 ( 171123 hom. )

Consequence

GRIN2B
NM_000834.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.13

Publications

34 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 12-13563704-G-A is Benign according to our data. Variant chr12-13563704-G-A is described in ClinVar as Benign. ClinVar VariationId is 129204.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.504 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000834.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
NM_000834.5
MANE Select
c.3534C>Tp.His1178His
synonymous
Exon 14 of 14NP_000825.2Q13224
GRIN2B
NM_001413992.1
c.3534C>Tp.His1178His
synonymous
Exon 15 of 15NP_001400921.1A0A8D9PHB2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
ENST00000609686.4
TSL:1 MANE Select
c.3534C>Tp.His1178His
synonymous
Exon 14 of 14ENSP00000477455.1Q13224
GRIN2B
ENST00000630791.3
TSL:5
c.3534C>Tp.His1178His
synonymous
Exon 15 of 15ENSP00000486677.3A0A0D9SFK0
GRIN2B
ENST00000637214.1
TSL:5
c.69+44899C>T
intron
N/AENSP00000489997.1A0A1B0GU78

Frequencies

GnomAD3 genomes
AF:
0.384
AC:
58380
AN:
151912
Hom.:
12922
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.201
Gnomad AMI
AF:
0.521
Gnomad AMR
AF:
0.448
Gnomad ASJ
AF:
0.454
Gnomad EAS
AF:
0.0143
Gnomad SAS
AF:
0.232
Gnomad FIN
AF:
0.417
Gnomad MID
AF:
0.522
Gnomad NFE
AF:
0.509
Gnomad OTH
AF:
0.402
GnomAD2 exomes
AF:
0.399
AC:
99507
AN:
249604
AF XY:
0.398
show subpopulations
Gnomad AFR exome
AF:
0.195
Gnomad AMR exome
AF:
0.460
Gnomad ASJ exome
AF:
0.447
Gnomad EAS exome
AF:
0.0139
Gnomad FIN exome
AF:
0.413
Gnomad NFE exome
AF:
0.508
Gnomad OTH exome
AF:
0.431
GnomAD4 exome
AF:
0.469
AC:
685715
AN:
1461154
Hom.:
171123
Cov.:
56
AF XY:
0.463
AC XY:
336620
AN XY:
726932
show subpopulations
African (AFR)
AF:
0.192
AC:
6418
AN:
33478
American (AMR)
AF:
0.459
AC:
20504
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.448
AC:
11707
AN:
26136
East Asian (EAS)
AF:
0.0125
AC:
495
AN:
39700
South Asian (SAS)
AF:
0.246
AC:
21184
AN:
86258
European-Finnish (FIN)
AF:
0.413
AC:
21791
AN:
52778
Middle Eastern (MID)
AF:
0.447
AC:
2578
AN:
5768
European-Non Finnish (NFE)
AF:
0.517
AC:
575008
AN:
1111940
Other (OTH)
AF:
0.431
AC:
26030
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
23094
46189
69283
92378
115472
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16216
32432
48648
64864
81080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.384
AC:
58396
AN:
152030
Hom.:
12927
Cov.:
32
AF XY:
0.377
AC XY:
27991
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.201
AC:
8338
AN:
41494
American (AMR)
AF:
0.449
AC:
6860
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.454
AC:
1577
AN:
3470
East Asian (EAS)
AF:
0.0143
AC:
74
AN:
5168
South Asian (SAS)
AF:
0.232
AC:
1117
AN:
4816
European-Finnish (FIN)
AF:
0.417
AC:
4413
AN:
10574
Middle Eastern (MID)
AF:
0.527
AC:
154
AN:
292
European-Non Finnish (NFE)
AF:
0.509
AC:
34546
AN:
67922
Other (OTH)
AF:
0.401
AC:
843
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1691
3383
5074
6766
8457
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
546
1092
1638
2184
2730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.465
Hom.:
68627
Bravo
AF:
0.380
Asia WGS
AF:
0.139
AC:
488
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
3
not provided (3)
-
-
1
Developmental and epileptic encephalopathy, 27 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Intellectual disability, autosomal dominant 6 (1)
-
-
1
Intellectual disability, autosomal dominant 6;C4015316:Developmental and epileptic encephalopathy, 27 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
3.6
DANN
Benign
0.53
PhyloP100
1.1
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1806191; hg19: chr12-13716638; COSMIC: COSV74204642; COSMIC: COSV74204642; API